The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Machine learning to identify biomarkers of response to immunotherapy in KRAS wildtype (KRASwt) non-small cell lung cancer (NSCLC).
 
Daniel Boiarsky
Stock and Other Ownership Interests - Tectonic Therapeutic; Tectonic Therapeutic (I)
 
Lingzhi Hong
No Relationships to Disclose
 
Biagio Ricciuti
Honoraria - Targeted Oncology
Consulting or Advisory Role - Abbvie; Amgen; AstraZeneca; Bayer; Bristol-Myers Squibb; Caris Life Sciences; Guidepoint Inc; Regeneron
Research Funding - AstraZeneca (Inst)
 
Alissa Cooper
Honoraria - Ideology Health; Intellisphere; MedStar Health; MJH Life Sciences; Peer Direct; Physician's Education Resource, LLC
Consulting or Advisory Role - Amgen; Boehringer Ingelheim; Daiichi Sankyo/Astra Zeneca; Gilead Sciences; Novartis; Regeneron
Research Funding - Abbvie (Inst); Amgen (Inst); Daiichi Sankyo/Astra Zeneca (Inst); Merck (Inst); Monte Rosa Therapeutics (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Gilead Sciences
 
Maliazurina Saad
No Relationships to Disclose
 
Arielle Elkrief
Honoraria - Astrazeneca; Bristol-Myers Squibb; EMD Serono; Merck
Consulting or Advisory Role - Bristol Myers Squibb; Sanofi Pasteur
Research Funding - AstraZeneca (Inst); GMT Science; Kanvas Bioscience (Inst); Merck (Inst)
Other Relationship - Canadian Institutes of Health Research (CIHR); Cedars Cancer Center; Royal College of Surgeons and Physicians of Canada
 
Alessandro Di Federico
No Relationships to Disclose
 
Muhammad Aminu
No Relationships to Disclose
 
Waree Rinsurongkawong
No Relationships to Disclose
 
Xiuning Le
Consulting or Advisory Role - Abbvie; ABION; Allyst; ArriVent Biopharma; ArriVent Biopharma; AstraZeneca; Aviston; Bayer; Black Diamond Therapeutics; BlossomHill Therapeutics; Blueprint Medicines; Boehringer Ingelheim; Daiichi Sankyo/Lilly; EMD Serono; Hengrui Therapeutics; Janssen Oncology; Lilly; Merus; Novartis; PineTree; Regeneron; Spectrum Pharmaceuticals; Systimmune; Taiho Pharmaceutical
Research Funding - ArriVent Biopharma (Inst); Boehringer Ingelheim (Inst); EMD Serono (Inst); Janssen (Inst); Lilly (Inst); Regeneron (Inst); Teligene (Inst)
Travel, Accommodations, Expenses - EMD Serono; Johnson & Johnson/Janssen; Regeneron; Spectrum Pharmaceuticals
 
Jia Luo
No Relationships to Disclose
 
Jia Wu
No Relationships to Disclose
 
Don Gibbons
Stock and Other Ownership Interests - Exact Sciences; Nektar
Honoraria - IDEOlogy Health
Consulting or Advisory Role - Aktis Oncology; AstraZeneca; Lilly; Menarini; Onconova Therapeutics; Sanofi
Research Funding - Astellas Pharma; AstraZeneca (Inst); Boehringer Ingelheim (Inst); Janssen; Lilly; Mirati Therapeutics (Inst); NGM Biopharmaceuticals; Ribon Therapeutics; Takeda
Travel, Accommodations, Expenses - AstraZeneca/MedImmune; BerGenBio; Takeda
 
John Heymach
Employment - MD Anderson Cancer Center
Consulting or Advisory Role - Abbvie; ALK Positive; ArriVent Biopharma; AstraZeneca; BioNtech; Boehringer Ingelheim; Bristol-Myers Squibb; EMD Serono; Genentech/Roche; GlaxoSmithKline; Janssen; Jazz Pharmaceuticals; Lilly (Inst); Mirati Therapeutics; ModeX Therapeutics; Novartis; Ottimo Pharma; Regeneron; Sanofi/Aventis; Spectrum Pharmaceuticals; Taiho Pharmaceutical; Takeda
Research Funding - AstraZeneca (Inst); Boehringer Ingelheim (Inst); Mirati Therapeutics; Spectrum Pharmaceuticals; Takeda (Inst)
Patents, Royalties, Other Intellectual Property - Licensing agreement between Spectrum and MD Anderson (including myself) regarding intellectual property for treatment of EGFR and HER2 exon 20 mutations; Patents pending regarding classification of EGFR mutations; Patents pending regarding subtyping of SCLC lung cancer.
 
Ferdinandos Skoulidis
Stock and Other Ownership Interests - BioNTech; Moderna Therapeutics
Honoraria - Curio Science; DAVA Oncology; ESMO; IDEOlogy Health; Intellisphere; Intellisphere; Japanese Lung Cancer Society; McGill Universite de Montreal; Medscape; MJH Life Sciences; Moving Innovation and Technology; PER; Physicans' Education Resource; RV Mais
Consulting or Advisory Role - Amgen; AstraZeneca; BeiGene; BergenBio; Bridgebio; Bristol Myers Squibb Foundation; Calithera Biosciences; Genmab; Guardant Health; Hookipa Pharma; Intellisphere; Lilly; Lilly; Medscape; Merck; Navire; Novartis; Novocure; Regeneron; Revolution Medicines; Roche/Genentech; Tango Therapeutics
Research Funding - AIMM Therapeutics (I); Amgen (Inst); Merck (Inst); Mirati Therapeutics (Inst); Novartis (Inst); Pfizer (Inst); Revolution Medicines (Inst)
Travel, Accommodations, Expenses - American Association for Cancer Research; Curio Science; Dava Oncology; IASLC; IDEOlogy Health; MI&T; MJH Life Sciences; PER
 
So Yeon Kim
Consulting or Advisory Role - Boehringer Ingelheim; Genentech; Revolution Medicines
Research Funding - Abbvie (Inst); Alentis Therapeutics (Inst); AstraZeneca (Inst); Bioinvent (Inst); Boehringer Ingelheim (Inst); Bridgebio (Inst); Bristol Myers Squibb Foundation (Inst); DynamiCure Biotechnology (Inst); Genentech (Inst); Genmab (Inst); Gilead Sciences (Inst); Loxo/Lilly (Inst); MediLink Therapeutics (Inst); Merck (Inst); Mirati Therapeutics (Inst); Monte Rosa Therapeutics (Inst); Pfizer (Inst); Seagen (Inst); Synthekine (Inst); Takeda (Inst); Vaccibody (Inst)
 
Adam Schoenfeld
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; BioNTech SE; Boehringer Ingelheim; Bristol-Myers Squibb; cTRL; Foresight Diagnostics; GlaxoSmithKline; Immunocore; Iovance Biotherapeutics; Obsidian Therapeutics; Oxford BioTherapeutics; Prelude Therapeutics; Regeneron; Roche; Synthekine
Research Funding - AffiniT therapeutics (Inst); Amgen (Inst); AstraZeneca; BioNTech SE; Bristol-Myers Squibb (Inst); Clasp Therapeutics (Inst); GlaxoSmithKline (Inst); Harpoon therapeutics (Inst); Iovance Biotherapeutics (Inst); Legend Biotech (Inst); Lilly; Merck (Inst); PACT Pharma (Inst); Roche/Genentech; Synthekine (Inst)
Travel, Accommodations, Expenses - Iovance Biotherapeutics; Legend Biotech; Obsidian Therapeutics; Regeneron
Other Relationship - Achilles Therapeutics; Amgen; Bristol-Myers Squibb; GlaxoSmithKline; Harpoon therapeutics; Instil Bio; Iovance Biotherapeutics; Merck; PACT Pharma
 
Mark Awad
Consulting or Advisory Role - Affini-T Therapeutics; AstraZeneca; AstraZeneca; Bristol-Myers Squibb; Coherus Biosciences; EMD Serono; Foundation Medicine; Gritstone Bio; Instil Bio; Janssen; Merck; Mirati Therapeutics; Novartis; Pfizer; Regeneron
Research Funding - Amgen (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Lilly (Inst)
Travel, Accommodations, Expenses - Bristol Myers Squibb Foundation
 
Jianjun Zhang
Honoraria - BeiGene; CancerNet; Geneplus; Geneplus; Hengrui Medicine; innovent biologics; Innovent Biologics; Innovent Biologics; Origimed; Roche; Roche China; Sino-USA Biomedical Platform; Suzhou Medical Association; Takeda; Varian Medical Systems; Zhejiang Cancer Hospital; Zhejiang Cancer Hospital; Zhejiang Cancer Hospital
Consulting or Advisory Role - AstraZeneca; AstraZeneca; AstraZeneca; Capital Medical University; fortvita biologics; Geneplus; Hunan Cancer Hospital; Johnson & Johnson/Janssen; Novartis
Research Funding - Helius; Merck; Novartis; Summit Therapeutics
Travel, Accommodations, Expenses - innovent biologics; Zhejiang Cancer Hospital
 
Natalie Vokes
Honoraria - Cardinal Health; Genentech; Guardant Health; HMP; Medlive; OMNI Health Media; OncLive/MJH Life Sciences; PlatformQ Health; Sanofi; Tango Therapeutics; Targeted Oncology
Consulting or Advisory Role - Amgen; AstraZeneca; Catalyst Pharmaceuticals; EMD Serono; ImmunityBio; Lilly; OncoCyte; Oncohost; Pfizer; Regeneron; Remedy Health; Sanofi; Sanofi/Regeneron; Summit pharmaceuticals; Tempus; Xencor
Research Funding - Amgen; Bristol Myers Squibb; Circulo; EMD Serono/Merck; IDEAYA Biosciences; Mirati Therapeutics; OncoCyte; Sanofi; Summit Health
Travel, Accommodations, Expenses - Regeneron